Mannkind (MNKD) Total Liabilities (2010 - 2026)
Mannkind (MNKD) reported Total Liabilities of $803.6 million for Q1 2026, up 71.43% year-over-year from $468.8 million in Q1 2025, and down 4.7% on a QoQ basis from $843.2 million in Q4 2025.
Mannkind (MNKD) has 17 years of Total Liabilities data on file, last reported at $803.6 million in Q1 2026.
- Quarterly Total Liabilities rose 71.43% year-over-year to $803.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $803.6 million (up 71.43% YoY) and the FY2025 annual result came in at $843.2 million, up 78.4% from the prior year.
- Total Liabilities fell to $803.6 million in Q1 2026 per MNKD's latest filing, from $843.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $843.2 million in Q4 2025 and bottomed at $145.8 million in Q4 2023.
- The 5-year median for Total Liabilities is $547.0 million (2022), against an average of $568.7 million.
- The widest annual swing landed in 2024, when Total Liabilities soared 224.16%; it then sank 34.06% in 2025.
- Tracing MNKD's Total Liabilities over 5 years: stood at $531.5 million in 2022, then plunged by 72.57% to $145.8 million in 2023, then soared by 224.16% to $472.7 million in 2024, then jumped by 78.4% to $843.2 million in 2025, then retreated by 4.7% to $803.6 million in 2026.
- Per Business Quant, the three latest MNKD Total Liabilities figures stand at $803.6 million (Q1 2026), $843.2 million (Q4 2025), and $539.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 803.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 803.60 Mn |
| Dec 31, 2025 | 843.20 Mn |
| Sep 30, 2025 | 539.19 Mn |
| Jun 30, 2025 | 466.74 Mn |
| Mar 31, 2025 | 468.76 Mn |
| Dec 31, 2024 | 472.66 Mn |
| Sep 30, 2024 | 674.13 Mn |
| Jun 30, 2024 | 669.62 Mn |
| Mar 31, 2024 | 710.85 Mn |
| Dec 31, 2023 | 145.81 Mn |
| Sep 30, 2023 | 572.11 Mn |
| Jun 30, 2023 | 573.91 Mn |
| Mar 31, 2023 | 553.53 Mn |
| Sep 30, 2022 | 531.51 Mn |
| Jun 30, 2022 | 532.85 Mn |
| Mar 31, 2022 | 540.38 Mn |
| Dec 31, 2021 | 530.51 Mn |
| Sep 30, 2021 | 422.90 Mn |
| Jun 30, 2021 | 436.34 Mn |
| Mar 31, 2021 | 493.00 Mn |
| Dec 31, 2020 | 289.03 Mn |
| Sep 30, 2020 | 282.10 Mn |
| Jun 30, 2020 | 282.49 Mn |
| Mar 31, 2020 | 278.26 Mn |
| Dec 31, 2019 | 284.25 Mn |
| Sep 30, 2019 | 279.85 Mn |
| Jun 30, 2019 | 277.79 Mn |
| Mar 31, 2019 | 288.97 Mn |
| Dec 31, 2018 | 282.79 Mn |
| Sep 30, 2018 | 250.80 Mn |
| Jun 30, 2018 | 268.77 Mn |
| Mar 31, 2018 | 285.09 Mn |
| Dec 31, 2017 | 299.31 Mn |
| Sep 30, 2017 | 307.50 Mn |
| Jun 30, 2017 | 300.62 Mn |
| Mar 31, 2017 | 283.91 Mn |
| Dec 31, 2016 | 290.66 Mn |
| Sep 30, 2016 | 334.82 Mn |
| Jun 30, 2016 | 506.01 Mn |
| Mar 31, 2016 | 466.74 Mn |
| Dec 31, 2015 | 476.74 Mn |
| Sep 30, 2015 | 402.58 Mn |
| Jun 30, 2015 | 468.03 Mn |
| Mar 31, 2015 | 457.05 Mn |
| Dec 31, 2014 | 468.21 Mn |
| Sep 30, 2014 | 427.50 Mn |
| Jun 30, 2014 | 282.68 Mn |
| Mar 31, 2014 | 207.02 Mn |
| Dec 31, 2013 | 289.36 Mn |
| Sep 30, 2013 | 455.33 Mn |
| Jun 30, 2013 | 364.79 Mn |
| Mar 31, 2013 | 362.00 Mn |
| Dec 31, 2012 | 361.99 Mn |
| Sep 30, 2012 | 486.58 Mn |
| Jun 30, 2012 | 484.77 Mn |
| Mar 31, 2012 | 528.81 Mn |
| Dec 31, 2011 | 513.21 Mn |
| Sep 30, 2011 | 504.82 Mn |
| Jun 30, 2011 | 473.74 Mn |
| Dec 31, 2010 | 462.79 Mn |